Marc Brøndum

Experienced board member with a strong track record of driving strategic value and operational impact. Brings extensive experience in optimizing complex processes, aligning stakeholders, and delivering scalable solutions. Committed to advancing the Danish-Swiss Chamber of Commerce through focused member retention, active engagement, and sustainable growth of the membership base.

I lead organisations with one purpose:
Turning vision into real, focused progress - grounded in user needs and strategic clarity. My leadership is defined by the ability to:
- Create direction in complexity
- Build and maintain sharp focus
- Align teams across business and tech
- Deliver solutions that are feasible, profitable, and valuable for real users Whether launching new offerings, leading in uncertainty, or refining product portfolios, I ensure that execution is anchored in deep user understanding and governed decision-making. I work where bold ambition meets operational reality:
- Translating insight into traction
- Building cross-functional trust
- And ensuring the right things get done When relevant - This is how your business strategy becomes My business to ensure execution - and how visions are realized.

advisor for one of BMD spin outs

In my role at Orifarm, I was responsible for cleaning up and optimizing the R&D and development pipelines, focusing on both efficiency and strategic alignment. I have implemented scalable governance models, enabling the company to prioritize high-impact projects and drive better ROI, particularly in the context of M&A opportunities. • Pipeline Optimization: Successfully designed and implemented a modular, scalable transformation model that improved pipeline efficiency, ensuring strategic project focus and execution. • Governance and Digital Transformation: Installed a new governance framework and data-driven processes, leading to more accurate pipeline prioritization and a significant increase in project completion rates. • Stakeholder Alignment: Spearheaded the implementation of tools and processes for better resource allocation, increasing decision-making clarity across internal teams and aligning stakeholders around strategic goals. • M&A Support: Led development project managers through key M&A integrations, ensuring seamless project execution and alignment with corporate goals.

At Wellspect, I led the digital transformation efforts aimed at improving customer engagement and operational efficiency within the commercial functions. By restructuring the digital platform and refining data strategies, I increased the effectiveness of customer retention and acquisition initiatives, driving greater value from digital opportunities. • Digital & Data Strategy: Redefined the company's digital and data roadmap, resulting in improved tracking and engagement metrics for customer retention and acquisition. • Matrix Management: Managed cross-functional projects, leveraging matrix structures to drive efficiency and improve stakeholder roles and responsibilities. • ROI on Digital Transformation: Implemented pilot projects that demonstrated clear ROI, focusing on customer experience enhancements as a strategic growth driver.

Headhunted to lead the global transformation of ConvaTec's R&D pipeline, I spearheaded efforts to increase innovation speed, reduce costs, and align development efforts with consumer needs. My role required balancing strategic leadership with hands-on project management, ensuring that all innovation efforts were tightly aligned with market demands and corporate objectives. •​Drove restructuring of global R&D achieving operational leverage •​60 FTE global R&D organisation restructuring (process and organisation) •​+15% efficiency gain / +30% cost reduction •​Increased speed of early innovation by 50% (40+ External HUB org structure) •​Redefined and launched new modular platform on critical R&D workstreams (products) •​Integrated digital platforms and features to Innovation •​M/A RD integration ownership for technology and pipeline development •​Redesigned innovation pipeline with consumer focus in chronic care portfolio •​Awarded IF Award for new consumer designed catheter pivoting the consumer journey in CvT •​Board access and reporting on transformation development in RD •​Part of Exec. Management extended leadership group • Establishing Stage Gate model and governance • Professionalized PMO and ressource/project prioritization

Change leader driving Consumer and Customer centricity into technical and Science heavy industries ensuring that science experts is delivering on data driven needs providing commercial value. Headhunted by Coloplast to transform and introduce global design DNA and introduce user centric innovation approach within RD •​Awarded RedDot Best of Best, IF and MDEA Award for SpeediCath Compact Eve •​Introduced Coloplast Design DNA across portfolio achieving strong Brand awareness •​Brand ambassador – Ensured commercial branding was founded in the Design DNA •​Introduced digital healthcare as anchor in all products assessment •​Shortened time-to-market by 12% through disciplined approach to user insights •​Achieved dominant market positions with innovative chronic care development •​Responsible for Ostomy platform development structure •​Introduced robust approach to radical/incremental products & services development •​Incorporated consumer products into new DTC agenda •​Leadership of processes and structure installing Industrial Design as strategic pillar in RD

At Coloplast, I was brought in to transform the company's innovation approach by integrating design DNA aand consumer centricuty into the product development process. I successfully shortened time-to-market by 12% and launched several high-impact products, while also building a more consumer-driven approach to innovation in addition to tech Innovation. •​Awarded RedDot Best of Best, IF and MDEA Award for SpeediCath Compact Eve •​Introduced Coloplast Design DNA across portfolio achieving strong Brand awareness •​Brand ambassador – Ensured commercial branding was founded in the Design DNA •​Introduced digital healthcare as anchor in all products assessment •​Shortened time-to-market through disciplined approach to user insights •​Achieved dominant market positions with innovative chronic care development •​Responsible for Ostomy platform development structure •​Introduced robust approach to radical/incremental products & services development •​Incorporated consumer products into new DTC agenda